| CAS NO: | 14636-12-5 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selectivevasopressin V1 receptoragonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research[1][2][3][4][5]. | ||||||||||||||||
| IC50& Target | Vasopressin V1 receptor[1] | ||||||||||||||||
| 体外研究 (In Vitro) | Terlipressin (25 nM; 24-72 hours; IEC-6 cells) treatment significantly improves cell viability, proliferation and apoptosis in IEC-6 cells[1]. Cell Proliferation Assay[1]
| ||||||||||||||||
| 体内研究 (In Vivo) | Using a mouse nonlethal hepatic ischemia-reperfusion (IR) model, Terlipressin administration significantly ameliorates IR-induced liver apoptosis, necrosis and inflammation[3]. | ||||||||||||||||
| Clinical Trial | |||||||||||||||||
| 分子量 | 1227.37 | ||||||||||||||||
| Formula | C52H74N16O15S2 | ||||||||||||||||
| CAS 号 | 14636-12-5 | ||||||||||||||||
| Sequence | Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge: Cys4-Cys9) | ||||||||||||||||
| Sequence Shortening | GGGCYFQNCPKG-NH2 (Disulfide bridge: Cys4-Cys9) | ||||||||||||||||
| 中文名称 | 特利加压素 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. | ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 100 mg/mL(81.48 mM;Need ultrasonic) 配制储备液
In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
